|
Removal from Official List
|
27 September 2022 at 12:20pm
|
|
Scheme of Arrangement has been Implemented
|
26 September 2022 at 4:50pm
|
|
Ceasing to be a substantial holder
|
20 September 2022 at 8:30am
|
|
Becoming a substantial holder
|
19 September 2022 at 8:45am
|
|
Notification of cessation of securities - RAP
|
16 September 2022 at 6:25pm
|
|
Ceasing to be a substantial holder
|
16 September 2022 at 9:40am
|
|
Suspension from Official Quotation
|
15 September 2022 at 7:25pm
|
|
Scheme of Arrangement becomes effective
|
15 September 2022 at 1:15pm
|
|
Scheme of Arrangement - Court Approval
|
14 September 2022 at 12:50pm
|
|
Becoming a substantial holder
|
8 September 2022 at 7:25pm
|
|
Results of Scheme Meeting
|
7 September 2022 at 4:40pm
|
|
Scheme Meeting - Chairman's Address & Presentation
|
7 September 2022 at 2:20pm
|
|
Becoming a substantial holder
|
5 September 2022 at 11:05am
|
|
Appendix 4G
|
30 August 2022 at 9:35am
|
|
Corporate Governance Statement
|
30 August 2022 at 9:20am
|
|
Appendix 4E and Annual Report
|
30 August 2022 at 9:10am
|
|
Dispatch of Second Supplementary Scheme Booklet
|
29 August 2022 at 4:05pm
|
|
Second Supplementary Scheme Booklet
|
25 August 2022 at 2:25pm
|
|
Correction to ASX announcement
|
19 August 2022 at 2:55pm
|
|
Adjournment of Scheme Meeting to a date to be determined
|
19 August 2022 at 2:35pm
|
|
Best and Final Confirmation and Bridging Loan
|
16 August 2022 at 5:50pm
|
|
Dispatch of Supplementary Scheme Booklet
|
8 August 2022 at 6:59pm
|
|
Pfizer raises scheme consideration to A$0.208 per share
|
5 August 2022 at 6:15pm
|
|
Correction to ASX announcement
|
3 August 2022 at 5:25pm
|
|
Entry into amended and restated Scheme Implementation Deed
|
3 August 2022 at 11:05am
|
|
Investor Conference Call Notification
|
2 August 2022 at 6:05pm
|
|
Quarterly Activities Report and Appendix 4C
|
27 July 2022 at 9:45am
|
|
Quarterly Results and Investor Conference Call Notification
|
25 July 2022 at 9:45am
|
|
Study shows efficacy of ResAppDx use with masks
|
22 July 2022 at 9:45am
|
|
Dispatch of Scheme Booklet
|
20 July 2022 at 5:05pm
|
|
Clarification - Scheme Booklet registered with ASIC
|
20 July 2022 at 4:50pm
|
|
Scheme Update - ACCC condition precedent satisfied
|
18 July 2022 at 12:50pm
|
|
Scheme Booklet registered with ASIC
|
18 July 2022 at 12:20pm
|
|
Results of First Court Hearing
|
15 July 2022 at 5:35pm
|
|
Medgate Licence Agreement Clarification Announcement
|
11 July 2022 at 9:40am
|
|
Medgate extends licence agreement and plans to expand use
|
7 July 2022 at 9:35am
|
|
ResApp receives FDA 510(k) clearance for SleepCheckRx
|
6 July 2022 at 9:50am
|
|
Cough detection patent granted in Australia and Japan
|
5 July 2022 at 9:25am
|
|
Scheme Update
|
30 June 2022 at 3:00pm
|
|
ResApp to present at Gold Coast Investment Showcase
|
23 June 2022 at 10:05am
|
|
Results from Data Confirmation Study
|
21 June 2022 at 10:10am
|
|
Trading Halt
|
20 June 2022 at 10:10am
|
|
Investor Webinar
|
17 June 2022 at 9:20am
|
|
Notification of cessation of securities - RAP
|
16 June 2022 at 6:55pm
|
|
Application for quotation of securities - RAP
|
16 June 2022 at 5:05pm
|
|
Notification of cessation of securities - RAP
|
14 June 2022 at 7:05pm
|
|
Reinstatement to Official Quotation
|
14 June 2022 at 12:55pm
|
|
Increased Scheme Consideration from Pfizer
|
14 June 2022 at 12:55pm
|
|
Voluntary Suspension Extension
|
8 June 2022 at 1:30pm
|
|
Voluntary Suspension Extension
|
6 June 2022 at 2:55pm
|
ResApp Health